186 related articles for article (PubMed ID: 38635549)
1. Predisposing deleterious variants in the cancer-associated human kinases in the global populations.
Khan SA; Anwar M; Gohar A; Roosan MR; Hoessli DC; Khatoon A; Shakeel M
PLoS One; 2024; 19(4):e0298747. PubMed ID: 38635549
[TBL] [Abstract][Full Text] [Related]
2. Multilayer View of Pathogenic SNVs in Human Interactome through In Silico Edgetic Profiling.
Cui H; Zhao N; Korkin D
J Mol Biol; 2018 Sep; 430(18 Pt A):2974-2992. PubMed ID: 30017919
[TBL] [Abstract][Full Text] [Related]
3. Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis.
Min BJ; Kang YK; Chung YG; Seo ME; Chang KB; Joo MW
Clin Orthop Relat Res; 2020 Nov; 478(11):2442-2450. PubMed ID: 32281771
[TBL] [Abstract][Full Text] [Related]
4. Germline genetic variants in men with prostate cancer and one or more additional cancers.
Pilié PG; Johnson AM; Hanson KL; Dayno ME; Kapron AL; Stoffel EM; Cooney KA
Cancer; 2017 Oct; 123(20):3925-3932. PubMed ID: 28657667
[TBL] [Abstract][Full Text] [Related]
5. Distribution bias analysis of germline and somatic single-nucleotide variations that impact protein functional site and neighboring amino acids.
Pan Y; Yan C; Hu Y; Fan Y; Pan Q; Wan Q; Torcivia-Rodriguez J; Mazumder R
Sci Rep; 2017 Feb; 7():42169. PubMed ID: 28176830
[TBL] [Abstract][Full Text] [Related]
6. Rare genetic mutations in Pakistani patients with dilated cardiomyopathy.
Shakeel M; Irfan M; Khan IA
Gene; 2018 Oct; 673():134-139. PubMed ID: 29886034
[TBL] [Abstract][Full Text] [Related]
7. Whole genome sequencing of 35 individuals provides insights into the genetic architecture of Korean population.
Zhang W; Meehan J; Su Z; Ng HW; Shu M; Luo H; Ge W; Perkins R; Tong W; Hong H
BMC Bioinformatics; 2014; 15 Suppl 11(Suppl 11):S6. PubMed ID: 25350283
[TBL] [Abstract][Full Text] [Related]
8. Ancestry-specific predisposing germline variants in cancer.
Oak N; Cherniack AD; Mashl RJ; ; Hirsch FR; Ding L; Beroukhim R; Gümüş ZH; Plon SE; Huang KL
Genome Med; 2020 May; 12(1):51. PubMed ID: 32471518
[TBL] [Abstract][Full Text] [Related]
9. BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families.
Cherbal F; Salhi N; Bakour R; Adane S; Boualga K; Maillet P
Dis Markers; 2012; 32(6):343-53. PubMed ID: 22684231
[TBL] [Abstract][Full Text] [Related]
10. CADD score has limited clinical validity for the identification of pathogenic variants in noncoding regions in a hereditary cancer panel.
Mather CA; Mooney SD; Salipante SJ; Scroggins S; Wu D; Pritchard CC; Shirts BH
Genet Med; 2016 Dec; 18(12):1269-1275. PubMed ID: 27148939
[TBL] [Abstract][Full Text] [Related]
11. Germline mutations in candidate predisposition genes in individuals with cutaneous melanoma and at least two independent additional primary cancers.
Pritchard AL; Johansson PA; Nathan V; Howlie M; Symmons J; Palmer JM; Hayward NK
PLoS One; 2018; 13(4):e0194098. PubMed ID: 29641532
[TBL] [Abstract][Full Text] [Related]
12. Variant predictions in congenital adrenal hyperplasia caused by mutations in CYP21A2.
Prado MJ; Ligabue-Braun R; Zaha A; Rossetti MLR; Pandey AV
Front Pharmacol; 2022; 13():931089. PubMed ID: 36278220
[TBL] [Abstract][Full Text] [Related]
13. Germline CHEK2 Gene Mutations in Hereditary Breast Cancer Predisposition - Mutation Types and their Biological and Clinical Relevance.
Kleiblová P; Stolařová L; Křížová K; Lhota F; Hojný J; Zemánková P; Havránek O; Vočka M; Černá M; Lhotová K; Borecká M; Janatová M; Soukupová J; Ševčík J; Zimovjanová M; Kotlas J; Panczak A; Veselá K; Červenková J; Schneiderová M; Burócziová M; Burdová K; Stránecký V; Foretová L; Macháčková E; Tavandzis S; Kmoch S; Macůrek L; Kleibl Z
Klin Onkol; 2019; 32(Supplementum2):36-50. PubMed ID: 31409080
[TBL] [Abstract][Full Text] [Related]
14. Estimating the mutational load for cardiovascular diseases in Pakistani population.
Shakeel M; Irfan M; Khan IA
PLoS One; 2018; 13(2):e0192446. PubMed ID: 29420653
[TBL] [Abstract][Full Text] [Related]
15. Germ-line and somatic EPHA2 coding variants in lens aging and cataract.
Bennett TM; M'Hamdi O; Hejtmancik JF; Shiels A
PLoS One; 2017; 12(12):e0189881. PubMed ID: 29267365
[TBL] [Abstract][Full Text] [Related]
16. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL
Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067
[TBL] [Abstract][Full Text] [Related]
17. Germline cytoskeletal and extra-cellular matrix-related single nucleotide variations associated with distinct cancer survival rates.
Falasiri S; Rahman T; Tu YN; Fawcett TJ; Blanck G
Gene; 2018 Aug; 669():91-98. PubMed ID: 29778426
[TBL] [Abstract][Full Text] [Related]
18. Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations.
Wardell CP; Fujita M; Yamada T; Simbolo M; Fassan M; Karlic R; Polak P; Kim J; Hatanaka Y; Maejima K; Lawlor RT; Nakanishi Y; Mitsuhashi T; Fujimoto A; Furuta M; Ruzzenente A; Conci S; Oosawa A; Sasaki-Oku A; Nakano K; Tanaka H; Yamamoto Y; Michiaki K; Kawakami Y; Aikata H; Ueno M; Hayami S; Gotoh K; Ariizumi SI; Yamamoto M; Yamaue H; Chayama K; Miyano S; Getz G; Scarpa A; Hirano S; Nakamura T; Nakagawa H
J Hepatol; 2018 May; 68(5):959-969. PubMed ID: 29360550
[TBL] [Abstract][Full Text] [Related]
19. Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer.
Lee NY; Hum M; Zihara S; Wang L; Myint MK; Lim DW; Toh CK; Skanderup A; Samol J; Tan MH; Ang P; Lee SC; Tan EH; Lai GGY; Tan DSW; Yap YS; Lee ASG
Hum Genomics; 2023 Jul; 17(1):66. PubMed ID: 37461096
[TBL] [Abstract][Full Text] [Related]
20. Exome analysis reveals differentially mutated gene signatures of stage, grade and subtype in breast cancers.
Li Y; Wang X; Vural S; Mishra NK; Cowan KH; Guda C
PLoS One; 2015; 10(3):e0119383. PubMed ID: 25803781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
